These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10597090)

  • 21. Reduced dose salbutamol in comparison with standard dosage for symptom relief in asthma.
    Yates DH; Peters MJ; Keatings V; Thomas PS; Barnes PJ
    Eur Respir J; 1995 Nov; 8(11):1847-51. PubMed ID: 8620950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formoterol, a new long-acting beta 2 agonist, inhaled twice daily, in stable asthmatic subjects.
    Midgren B; Melander B; Persson G
    Chest; 1992 Apr; 101(4):1019-22. PubMed ID: 1348219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two new beta 2-adrenoceptor agonists, D-2343 and QH 25, studied in asthmatic patients.
    Löfdahl CG; Bengtsson B; Svedmyr K; Svedmyr N
    Allergy; 1982 Jul; 37(5):351-7. PubMed ID: 6127039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients.
    Marlin GE; Turner P
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):158-69. PubMed ID: 240780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of acute alteration in oxygen tension on the bronchodilator response to salbutamol in vitro and in vivo in man.
    Dagg KD; Clayton RA; Thomson LJ; Chalmers GW; McGrath JC; Thomson NC
    Pulm Pharmacol Ther; 2001; 14(2):99-105. PubMed ID: 11273790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of different nebulized bronchodilators on clinical efficacy and hypokalemia in asthmatic children.
    Hung CH; Hua YM; Lee MY; Tsai YG; Yang KD
    Acta Paediatr Taiwan; 2001; 42(5):287-90. PubMed ID: 11729705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacodynamics of inhalation broncholytic agents introduced in a single dose by nebulizer in patients with severe exacerbation of bronchial asthma].
    Tsoĭ AN; Apkhipov VV
    Ter Arkh; 2002; 74(3):17-21. PubMed ID: 11980113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial aggregation of bronchodilator response: a community-based study.
    Niu T; Rogus JJ; Chen C; Wang B; Yang J; Fang Z; Weiss ST; Xu X
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1833-7. PubMed ID: 11069822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral bronchodilators in the control of asthma.
    Rees PJ
    Natl Med J India; 1996; 9(4):153-4. PubMed ID: 8772328
    [No Abstract]   [Full Text] [Related]  

  • 30. Tolerance to beta-agonists during acute bronchoconstriction.
    Hancox RJ; Aldridge RE; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Town GI; Taylor DR
    Eur Respir J; 1999 Aug; 14(2):283-7. PubMed ID: 10515402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of salmeterol in patients with allergic bronchial asthma].
    Pacor ML; Biasi D; Cortina P; Maleknia T; Lunardi C
    Clin Ter; 1994 Aug; 145(8):131-4. PubMed ID: 7955958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Beta 2 agonists and the course of bronchial asthma].
    Chazan R; Droszcz W
    Pol Arch Med Wewn; 1992; 87(4-5):285-8. PubMed ID: 1355903
    [No Abstract]   [Full Text] [Related]  

  • 33. Determinants of the bronchodilation response to salbutamol on histamine-induced bronchoconstriction.
    Koskela HO; Kiviniemi V; Purokivi MK; Taivainen AH; Tukiainen HO
    Respir Med; 2006 Oct; 100(10):1760-6. PubMed ID: 16563715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levalbuterol: pharmacologic properties and use in the treatment of pediatric and adult asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6):583-91; quiz 591-2, 659. PubMed ID: 12839314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mild asthma is not due to bronchodilation.
    Díaz O; Barberà JA; Marrades R; Chung KF; Roca J; Rodriguez-Roisin R
    Am J Respir Crit Care Med; 1997 Jul; 156(1):17-22. PubMed ID: 9230720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment.
    Castle W; Fuller R; Hall J; Palmer J
    BMJ; 1993 Apr; 306(6884):1034-7. PubMed ID: 8098238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled formoterol during one year in asthma: a comparison with salbutamol.
    Arvidsson P; Larsson S; Löfdahl CG; Melander B; Svedmyr N; Wåhlander L
    Eur Respir J; 1991 Nov; 4(10):1168-73. PubMed ID: 1687129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma].
    Kimura T; Adachi M
    Nihon Rinsho; 2001 Oct; 59(10):1992-9. PubMed ID: 11676144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaler medicament effects on saliva and plaque pH in asthmatic children.
    Kargul B; Tanboga I; Ergeneli S; Karakoc F; Dagli E
    J Clin Pediatr Dent; 1998; 22(2):137-40. PubMed ID: 9643188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma.
    Newhouse MT; Chapman KR; McCallum AL; Abboud RT; Bowie DM; Hodder RV; Paré PD; Mesic-Fuchs H; Molfino NA
    Chest; 1996 Sep; 110(3):595-603. PubMed ID: 8797398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.